Judicialization of medicines: effectiveness of rights or break in public policies?
Autor(a) principal: | |
---|---|
Data de Publicação: | 2020 |
Outros Autores: | , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Revista de Saúde Pública |
Texto Completo: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0034-89102020000100305 |
Resumo: | ABSTRACT OBJECTIVE: To analyze whether lawsuits for medicines filed against the state of Rio Grande do Norte agree with medical-sanitary and pharmaceutical assistance management criteria established by the public policies of access to medicines in force in Brazil. METHODS: This is a descriptive and retrospective study of the individual lawsuits that claimed medicines in the state of Rio Grande do Norte between 2013 and 2017. Information was collected from the procedural documents on the requested medicines, the diagnoses referred and the origin of the medical prescription, in order to analyze medical-sanitary and pharmaceutical assistance management characteristics. RESULTS: We analyzed 987 lawsuits, which requested 1,517 medications. Of these, 60.7% were not part of the National List of Essential Medicines, and, in 75% of the cases, there was a therapeutic alternative in the Brazilian Unified Health System. In 13.6% of the actions, at least one drug was prescribed for off-label use. Prescribers of philanthropic and private services often request medicines not covered by the pharmaceutical care policy. Even judicialized drugs that are part of the national list are constantly requested for non-standard indications. CONCLUSIONS: Court decisions for the supply of medicines violate health rules and make it difficult to manage pharmaceutical assistance, which may weaken the implementation of these policies. |
id |
USP-23_99e913a95d1ca4e94475307237561280 |
---|---|
oai_identifier_str |
oai:scielo:S0034-89102020000100305 |
network_acronym_str |
USP-23 |
network_name_str |
Revista de Saúde Pública |
repository_id_str |
|
spelling |
Judicialization of medicines: effectiveness of rights or break in public policies?Access to Essential Medicines and Health TechnologiesHealth's Judicialization, legislation & jurisprudenceNational Policy of Pharmaceutical AssistanceRight to HealthABSTRACT OBJECTIVE: To analyze whether lawsuits for medicines filed against the state of Rio Grande do Norte agree with medical-sanitary and pharmaceutical assistance management criteria established by the public policies of access to medicines in force in Brazil. METHODS: This is a descriptive and retrospective study of the individual lawsuits that claimed medicines in the state of Rio Grande do Norte between 2013 and 2017. Information was collected from the procedural documents on the requested medicines, the diagnoses referred and the origin of the medical prescription, in order to analyze medical-sanitary and pharmaceutical assistance management characteristics. RESULTS: We analyzed 987 lawsuits, which requested 1,517 medications. Of these, 60.7% were not part of the National List of Essential Medicines, and, in 75% of the cases, there was a therapeutic alternative in the Brazilian Unified Health System. In 13.6% of the actions, at least one drug was prescribed for off-label use. Prescribers of philanthropic and private services often request medicines not covered by the pharmaceutical care policy. Even judicialized drugs that are part of the national list are constantly requested for non-standard indications. CONCLUSIONS: Court decisions for the supply of medicines violate health rules and make it difficult to manage pharmaceutical assistance, which may weaken the implementation of these policies.Faculdade de Saúde Pública da Universidade de São Paulo2020-01-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0034-89102020000100305Revista de Saúde Pública v.54 2020reponame:Revista de Saúde Públicainstname:Universidade de São Paulo (USP)instacron:USP10.11606/s1518-8787.2020054002301info:eu-repo/semantics/openAccessOliveira,Yonara Monique da CostaBraga,Bárbara Suellen FonsecaFarias,Andrezza DuartePereira,Sylvia Patrícia DantasFerreira,Maria Angela Fernandeseng2020-12-10T00:00:00Zoai:scielo:S0034-89102020000100305Revistahttp://www.scielo.br/scielo.php?script=sci_serial&pid=0034-8910&lng=pt&nrm=isoONGhttps://old.scielo.br/oai/scielo-oai.phprevsp@org.usp.br||revsp1@usp.br1518-87870034-8910opendoar:2020-12-10T00:00Revista de Saúde Pública - Universidade de São Paulo (USP)false |
dc.title.none.fl_str_mv |
Judicialization of medicines: effectiveness of rights or break in public policies? |
title |
Judicialization of medicines: effectiveness of rights or break in public policies? |
spellingShingle |
Judicialization of medicines: effectiveness of rights or break in public policies? Oliveira,Yonara Monique da Costa Access to Essential Medicines and Health Technologies Health's Judicialization, legislation & jurisprudence National Policy of Pharmaceutical Assistance Right to Health |
title_short |
Judicialization of medicines: effectiveness of rights or break in public policies? |
title_full |
Judicialization of medicines: effectiveness of rights or break in public policies? |
title_fullStr |
Judicialization of medicines: effectiveness of rights or break in public policies? |
title_full_unstemmed |
Judicialization of medicines: effectiveness of rights or break in public policies? |
title_sort |
Judicialization of medicines: effectiveness of rights or break in public policies? |
author |
Oliveira,Yonara Monique da Costa |
author_facet |
Oliveira,Yonara Monique da Costa Braga,Bárbara Suellen Fonseca Farias,Andrezza Duarte Pereira,Sylvia Patrícia Dantas Ferreira,Maria Angela Fernandes |
author_role |
author |
author2 |
Braga,Bárbara Suellen Fonseca Farias,Andrezza Duarte Pereira,Sylvia Patrícia Dantas Ferreira,Maria Angela Fernandes |
author2_role |
author author author author |
dc.contributor.author.fl_str_mv |
Oliveira,Yonara Monique da Costa Braga,Bárbara Suellen Fonseca Farias,Andrezza Duarte Pereira,Sylvia Patrícia Dantas Ferreira,Maria Angela Fernandes |
dc.subject.por.fl_str_mv |
Access to Essential Medicines and Health Technologies Health's Judicialization, legislation & jurisprudence National Policy of Pharmaceutical Assistance Right to Health |
topic |
Access to Essential Medicines and Health Technologies Health's Judicialization, legislation & jurisprudence National Policy of Pharmaceutical Assistance Right to Health |
description |
ABSTRACT OBJECTIVE: To analyze whether lawsuits for medicines filed against the state of Rio Grande do Norte agree with medical-sanitary and pharmaceutical assistance management criteria established by the public policies of access to medicines in force in Brazil. METHODS: This is a descriptive and retrospective study of the individual lawsuits that claimed medicines in the state of Rio Grande do Norte between 2013 and 2017. Information was collected from the procedural documents on the requested medicines, the diagnoses referred and the origin of the medical prescription, in order to analyze medical-sanitary and pharmaceutical assistance management characteristics. RESULTS: We analyzed 987 lawsuits, which requested 1,517 medications. Of these, 60.7% were not part of the National List of Essential Medicines, and, in 75% of the cases, there was a therapeutic alternative in the Brazilian Unified Health System. In 13.6% of the actions, at least one drug was prescribed for off-label use. Prescribers of philanthropic and private services often request medicines not covered by the pharmaceutical care policy. Even judicialized drugs that are part of the national list are constantly requested for non-standard indications. CONCLUSIONS: Court decisions for the supply of medicines violate health rules and make it difficult to manage pharmaceutical assistance, which may weaken the implementation of these policies. |
publishDate |
2020 |
dc.date.none.fl_str_mv |
2020-01-01 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0034-89102020000100305 |
url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0034-89102020000100305 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
10.11606/s1518-8787.2020054002301 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
text/html |
dc.publisher.none.fl_str_mv |
Faculdade de Saúde Pública da Universidade de São Paulo |
publisher.none.fl_str_mv |
Faculdade de Saúde Pública da Universidade de São Paulo |
dc.source.none.fl_str_mv |
Revista de Saúde Pública v.54 2020 reponame:Revista de Saúde Pública instname:Universidade de São Paulo (USP) instacron:USP |
instname_str |
Universidade de São Paulo (USP) |
instacron_str |
USP |
institution |
USP |
reponame_str |
Revista de Saúde Pública |
collection |
Revista de Saúde Pública |
repository.name.fl_str_mv |
Revista de Saúde Pública - Universidade de São Paulo (USP) |
repository.mail.fl_str_mv |
revsp@org.usp.br||revsp1@usp.br |
_version_ |
1748936506097008640 |